Can Serum Lactate on Admission to Intensive Care Predict Length of Stay? A Retrospective Analysis of Critically Ill Paediatric Oncology Patients.

ABSTRACT:

Introduction

Nearly 40% of hospitalised oncology patients are admitted to the paediatric intensive care unit (PICU). Clinicians utilise serum lactate as a biomarker to guide resuscitation and ongoing management of critically ill children. The significance of raised serum lactate remains unknown in oncology patients. Those who require an admission to the PICU have relatively poorer outcomes compared to those only managed on hospital wards, where there may be an increased tendency to apply additional interventions to normalise lactate. We assessed the association between serum lactate and the length of stay in PICU in paediatric oncology patients.

Patients and methods

We conducted a retrospective observational study of patients admitted to the oncology service, who had at leas

SUBMITTER: Sim MB 

PROVIDER: S-EPMC12397840 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature